Skip to main content

Table 1 Pulmonary hypertension rat models and pharmacologic treatment in the ten experimental groups

From: Simvastatin ameliorates established pulmonary hypertension through a heme oxygenase-1 dependent pathway in rats

Group (Abbreviation)

Treatment

Normal control (N)

Sham

Normal+Simvastatin (NS)

Simvastatin on days 21~23

MCT (M)

MCT on day 1

MCT+Simvastatin (MS)

MCT on day 1; simvastatin on days 21~23

MCT+Simvastatin+SnPP (MSP)

MCT on day 1; co-treated with simvastatin and SnPP on days 21~23

MCT+SnPP (MP)

MCT on day 1; SnPP on days 21~23

Chronic Hypoxia (H)

Placed in a hypobaric chamber for 24 days

Chronic Hypoxia+Simvastatin (HS)

Chronic hypoxia for 24 days, simvastatin on days 21~23

Chronic Hypoxia+Simvastatin+SnPP (HSP)

Chronic hypoxia for 24 days, co-treated with simvastatin and SnPP on days 21~23

Chronic Hypoxia+SnPP (HP)

Chronic hypoxia, SnPP on days 21~23